Capital Markets
[網上研討會] 政策引領創新: 捕捉中國科技及生物科技之潛力與機遇
Overview
2025年，恒生綜合指數中的12個行業指數，有4個行業的升幅高於大市。本次研討會將探討如何利用恒生生物科技指數追蹤潛力與機遇並存的領域 — 中國生物科技的黃金時代，並剖析恒生科技指數完善的産品生態系統如何全方位追蹤科技行業的表現，為投資者打造多元化投資組合。
Content
• 2025年市場表現亮點
• 生物科技之機遇
• 科技生態系統分析
• 最新指數介紹
Who should attend
此網上研討會主要針對資產管理人、財富管理經理、投資分析員、金融機構及持牌法團高級管理人員，如投資部主管、核心職能主管(MIC)、董事、法律及合規部門人員，基金經理，交易所買賣基金（ETF）發行人, 機構投資者，或對相關指數想要更深入瞭解的人士參與。
Speaker/Course Instructor
Gary CHIU
Mr Gary Chiu works as the Senior Vice President, Research & Insights at Hang Seng Indexes Company. His role is to build Hang Seng Indexes Company’s leading position among professional investors through insightful sharing.
He also oversees the marketing and branding strategy of the company. He has 20 years’ experience as Research Analyst covering power utilities, renewables and infrastructure sectors in Asia-Pacific during 1996-2016, and 4 years’ experience as an Investor Relations Director in a listed company in 2016-2020 before joining Hang Seng Indexes Company.
He also oversees the marketing and branding strategy of the company. He has 20 years’ experience as Research Analyst covering power utilities, renewables and infrastructure sectors in Asia-Pacific during 1996-2016, and 4 years’ experience as an Investor Relations Director in a listed company in 2016-2020 before joining Hang Seng Indexes Company.
Details
Code
TSBCM26000601
Date & Time
Wednesday, 11 Feb 2026 (12:20PM - 1:20PM)
Venue
Virtual Platform
Relevant Subject
Type 1 - Dealing in securities
Type 4 - Advising on securities
Type 9 - Asset management
Tags
New
Language
Trad. Chi / Cantonese
Hours
SFC:1.00, PWMA:1.00
Fees
All Member: HK$290
Staff of Corporate Member: HK$290
Chinese Securities Association of Hong Kong (HKCSA): HK$405
Non-Member: HK$580
HKSI Institute Staff: HK$0
Honorary Fellow Member: HK$0